Cardiff Oncology, Inc. Common Stock (CRDF) is a publicly traded Healthcare sector company. As of October 21, 2026, CRDF trades at $0.99 with a market cap of $72.47M and a P/E ratio of -1.22. CRDF moved +1.74% today. Year to date, CRDF is -64.70%; over the trailing twelve months it is -57.89%. Its 52-week range spans $0.76 to $4.56. Analyst consensus is buy with an average price target of $7.50. Rallies surfaces CRDF's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
5 analysts cover CRDF: 0 strong buy, 2 buy, 3 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $7.50.
| Metric | Value |
|---|---|
| Price | $0.99 |
| Market Cap | $72.47M |
| P/E Ratio | -1.22 |
| EPS | $-0.93 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.56 |
| 52-Week Low | $0.76 |
| Volume | 335.01K |
| Avg Volume | 0 |
| Revenue (TTM) | $488.00K |
| Net Income | $-41.44M |
| Gross Margin | 0.00% |
5 analysts cover CRDF: 0 strong buy, 2 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.50.